通知通告

新闻类别:通知通告
2016-12-26

【报告通知】Nanoparticles based theranostics

报告题目:Nanoparticles based theranostics
报告时间:2016年12月28日下午16:00-17:00
报告地点:武汉光电国家实验室G300
报 告 人:师冰洋 教授,博士生导师。河南大学-麦考瑞大学生物医学联合创新中心执行主任。中组部“千人计划”青年项目入选者。
邀 请 人:张智红 教授

Abstract:
Nanoparticles (NPs) are promising platform for theranostics applications such as bioimaging, diagnostics, drug delivery, gene delivery, biosensors and photodynamic therapy. NPs can be designed and developed based on a variety of core materials (metal, semiconductor, silica and organic polymers). During the synthesis process, the size and morphology can be controlled via the adjustment of reaction conditions, such as time, temperature and catalysts. The surface functionalization is other important field for NPs development, various surface functional groups and targeting ligands can be introduced onto the core materials as an additional dimension in regulating NP interfacial properties for further biomedical applications. During last five years, we have designed and developed various advanced nanoparticles including polymers based nanoparticles, nanogels based nanoparticles, dentrimer-like silica nanoparticles, gold-silica hybrid nanoparticles, mesoporous silica nanoparticles and upconvertion nanoparticles. Those developed nanoparticles have been applied in drug delivery, gene delivery, early stage cancer detection and photodynamic therapy, the promising results evidence that they will have potential applications in the future medicine.

Biography:
Dr. Bingyang Shi is currently a professor of biomedicine and the executive director of Henan University – Macquarie University joint research Centre for Biomedical Innovation. Dr Shi’s research focuses on the development of nanobiotechnology and advanced multifunctional bionanosystems for cancer and neurodegenerative disease diagnosis and therapy. He has been recognised as a rising star by receiving many awards including Macquarie University research fellowship, Yellow River fellowship, NHMRC-ARC Dementia Career Development fellowship and NHMRC Peter Doherty biomedical fellowship. He was also selected as 1000 Plan young scientist (under 40) in 2015. Dr. Shi received his B.S. degree from Henan University in 2006, Master degree in National Bioengineering Centre (Shanghai, China) in 2009 and Ph.D. degree from the University of Adelaide in 2013.

Research Interests:
1. Blood brain barrier cross for brain disease therapy.
2. Early stage diseases diagnosis
3. Bio-Nano interfaces.